<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Although <z:hpo ids='HP_0011998'>postprandial hyperglycemia</z:hpo> is recognized as an important target in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> treatment, information on the prevalence of <z:hpo ids='HP_0011998'>postprandial hyperglycemia</z:hpo> throughout the day is limited </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we assessed the prevalence of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> throughout the day in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients and healthy controls under standardized dietary, but otherwise free-living conditions </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: 60 male type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients (HbA(1c) 7.5±0.1% [58±1 mmol/mol]) and 24 age- and BMI-matched <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant controls were recruited to participate in a comparative study of daily glycemic control </plain></SENT>
<SENT sid="3" pm="."><plain>During a 3-day experimental period, blood <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations throughout the day were assessed by continuous <z:chebi fb="105" ids="17234">glucose</z:chebi> monitoring </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients experienced <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (<z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations &gt;10 mmol/L) 38±4% of the day </plain></SENT>
<SENT sid="5" pm="."><plain>Even <z:mp ids='MP_0002055'>diabetes</z:mp> patients with an HbA(1c) level below 7.0% (53 mmol/mol) experienced <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> for as much as 24±5% throughout the day </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> was negligible in the control group (3±1%) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> is highly prevalent throughout the day in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients, even in those patients with a HbA(1c) level well below 7.0% (53 mmol/mol) </plain></SENT>
<SENT sid="8" pm="."><plain>Standard medical care with prescription of oral blood <z:chebi fb="105" ids="17234">glucose</z:chebi> lowering medication does not provide ample protection against <z:hpo ids='HP_0011998'>postprandial hyperglycemia</z:hpo> </plain></SENT>
</text></document>